Loading clinical trials...

Performance of MOTO Medial® Unicompartmental Knee Arthroplasty | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITING

Performance of MOTO Medial® Unicompartmental Knee Arthroplasty

A Prospective, Multi-Center Study To Assess Performance of MOTO Medial® in Unicompartmental Knee Arthroplasty (UKA).

NCT03211663•Medacta USA

Summary

This is a prospective, multi-center study, designed to assess mid-term performance of the MOTO Medial® Unicompartmental Knee Arthroplasty (UKA), with patient report outcomes, clinical findings and radiographic analysis.

Detailed Description

This is a prospective, multi-center study, designed to assess mid-term performance of the MOTO Medial® UKA, with patient report outcomes, clinical findings and radiographic analysis. Additionally, several perioperative factors, medical and surgical history will be evaluated. Implant survival and complications will be detailed throughout the study. Data from pre-operative evaluation, day of surgery, and post-operatively at 4 weeks, 6 months, and years 1, 2 \& 5, will be collected.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Must be able to read, understand and provide written informed consent on the Institutional Review Board (IRB) approved Informed Consent Form (ICF).
•* Ability to understand and provide written authorization for use and disclosure of personal health information.
•* Subject who are able and willing to comply with the study protocol and follow-up visits.
•* Must be 18 years or older to participate.
•* Subjects must have medial knee disease in the affected knee compliant with the FDA-approved indications for use of MOTO Medial® UKA.
•* Must have had no prior arthroplasty to the medial compartment of the study knee.
•* Subjects must be able to return for the follow-up appointments, and have the mental capacity to cooperate and complete Patient Reported Outcome questionnaires, physical exam and radiographs.

Exclusion Criteria

•Knee ligament instability (deficiency of cruciate or collateral ligaments)
•* Inflammatory Arthritis
•* History of prior knee infection
•* History of Alcoholism or Drug Abuse
•* Currently on chemotherapy or radiation therapy for neoplastic disease. Medacta MOTO Medial® Version 1 Confidential Page 9 of 36 June 5, 2017
•* Currently on immunosuppressive medications including steroids
•* History of known sensitivity or allergy to materials used in orthopedic implants, specifically Titanium and Cobalt-Chrome alloys
•* Habitual use of narcotic pain medications prior to surgery (more than 3 doses or pills per week)
•* History of metabolic disorder affecting the skeletal system other than osteoarthritis or osteoporosis (e.g., Osteomalacia, Ricketts)
•* History of chronic pain issues for reasons other than knee pain.
+5 more criteria

Locations (5)

Unova Health Clinic

Lady Lake, Florida, United States

Ellis & Badenhausen Orthopaedics PSC

Louisville, Kentucky, United States

Ortho Montana

Billings, Montana, United States

Duke University

Durham, North Carolina, United States

Whole Health Joint Replacement

Meadville, Pennsylvania, United States

Key Dates

Start Date

October 9, 2017

Primary Completion Date

December 1, 2025

Completion Date

December 1, 2025

Last Updated

September 25, 2025

Enrollment

269

ESTIMATED participants

Conditions

Knee OsteoarthritisKnee ArthritisKnee Pain Chronic

Interventions

MOTO Medial® UKA

DEVICE

A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis

NCT07351968

Moderate Pain in Knee OsteoarthritisSevere Pain in Knee Osteoarthritis

View study

RECRUITINGNA

General vs Spinal in Total Joint Arthroplasty (TJA)

NCT06747494

Knee OsteoarthritisHip Osteoarthritis

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 25, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Performance of MOTO Medial® Unicompartmental Knee Arthroplasty

Inclusion Criteria

Exclusion Criteria

A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis

General vs Spinal in Total Joint Arthroplasty (TJA)

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression

ROAM OA: Functional and Patient Reported Outcomes Wearing a Knee Brace for Unicompartmental OA

Knee Osteoarthritis Rehabilitation Through Rotational Inertia

Cryoneurolysis Prior to Total Knee Arthroplasty (CRYO-TKA Trial)